U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous

Research Driven Investing Provides Stocks Research on Cytokinetics and Pluristem Therapeutics

Continue Reading

Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High

RDInvesting Provides Stocks Research on United Therapeutics and Viropharma

Continue Reading

Improvements in the Global Economy to Drive Global Demand for Oil Higher in 2013

Five Star Equities Provides Stock Research on Enerplus and Gran Tierra Energy

Continue Reading

High Yielding REITs Outperform Broader S&P 500 Index for the Fourth Consecutive Year

Five Star Equities Provides Stock Research on Newcastle Investment and RAIT Financial Trust

Continue Reading

Activision Blizzard and Take-Two Interactive Rise on Strong Earnings — China Considers Lifting Ban on Game Consoles

Five Star Equities Provides Stock Research on Activision Blizzard and Take-Two Interactive

Continue Reading

Video Game Industry Could Receive a Boost as China Considers Lifting Ban on Video Game Consoles

Five Star Equities Provides Stock Research on Electronic Arts and Majesco Entertainment

Continue Reading

U.S. Food and Drug Administration Approved 30% More Drugs in 2012

RDInvesting Provides Stocks Research on Celldex Therapeutics and Peregrine Pharmaceuticals

Continue Reading

Centers for Medicare and Medicaid Services Projects Health Care Spending to Grow From $2.8 Trillion to $4.8 Trillion by 2021

Research Driven Investing Provides Stocks Research on Centene and Molina Healthcare

Continue Reading

Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry-s Success

RDInvesting Provides Stocks Research on Alexza Pharmaceuticals and Savient Pharmaceuticals

Continue Reading

Advanced Energy Industries and MEMC Electronic Materials on the Upswing After Receiving “Buy” Rating from Citigroup.

RDInvesting Provides Stock Research on Advanced Energy Industries and MEMC Electronic Materials

Continue Reading